Literature DB >> 18881171

The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa.

M SVARTZ.   

Abstract

Entities:  

Keywords:  COLITIS/ulcerative; SALAZOPYRINE/therapy; SULFONAMIDES/toxicity

Mesh:

Substances:

Year:  1948        PMID: 18881171     DOI: 10.1111/j.0954-6820.1948.tb12083.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  9 in total

1.  In which phase of ulcerative colitis does colonic cancer occur.

Authors:  N SVARTZ; T GILLNAS
Journal:  Am J Dig Dis       Date:  1958-07

2.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 4.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 5.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

6.  Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.

Authors:  K Akahoshi; Y Chijiiwa; T Kabemura; H Okabe; Y Akamine; H Nawata
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

7.  Sulphasalazine desensitisation in patients with arthritis.

Authors:  C McCarthy; R Coughlan
Journal:  Ir J Med Sci       Date:  1994-05       Impact factor: 1.568

8.  Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.

Authors:  M Chatzinoff; J M Guarino; S L Corson; F R Batzer; L S Friedman
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

9.  Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis.

Authors:  Aziz Sener; Alper Sahbaz; Leyla Turker Sener; Merva Soluk Tekkesin; Bulent Kaya
Journal:  North Clin Istanb       Date:  2018-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.